Published clinical trials report a favorable safety profile for GHK-Cu with low rates of mild observations including localized application site irritation (5%), transient skin redness (3%), and itching (2%)

Medical history and medication review to flag any interactions or contraindications before prescribing Goal-specific protocol selection based on injury location, duration, and severity rather than a one-size-fits-all 500 mcg recommendation Written reconstitution and injection instructions with the exact mL and unit markings for the patients specific vial and prescribed dose Injection training for self-administration patients, either in-clinic or via telehealth video walkthrough Week-four check-in to assess response, adjust dose or frequency if needed, and confirm the patient is completing the cycle correctly Pharmacy-grade 503A product with verified purity, sterility, and potency from an FDA-registered compounding pharmacy For patients who have never injected a peptide before, we also review the BPC-157 benefits and mechanism in detail before starting the protocol so the patient understands what the peptide does, what to expect during the cycle, and what results realistically look like at four, eight, and twelve weeks

For individuals who want to maintain normal eating patterns, avoid central appetite manipulation, cannot tolerate GLP-1 side effects, or prefer targeted fat metabolism enhancement without hunger modification, AOD-9604 offers an alternative mechanism
That is one of the most important things to understand